Document is current
Any future updates will be listed below
-
Authors
Obionu, Ifeoma M.
Moore, Julie M. https://orcid.org/0000-0002-5031-3270
Zahradeen, Safiya
Galadanci, Hadiza
Huffman, Mark D. https://orcid.org/0000-0001-7412-2519
Mahmoud, Zainab https://orcid.org/0000-0002-5203-2253
- License Information
-
More Information
Article History
Received: 11 February 2026
Accepted: 8 June 2026
First Online: 2 July 2026
Competing interests
: Z.M. is supported by NIH/NHLBI grant K23HL173684. J.M.M. is supported by NIH/NIAID grant AI168923. M.D.H. is supported by NIH/NHLBI grant K24HL175228. M.D.H. has received travel support from the World Heart Federation and consulting fees from PwC Switzerland. M.D.H. has an appointment at The George Institute for Global Health, which has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. M.D.H. has pending patents for heart failure polypills. Other co-authors have no relevant disclosures.
